Medistim CCO buys shares, aligns interests with long-term performance

Mike Karim, Medistim ASA's chief commercial officer, purchased 2,211 shares in the company on November 7th. The transaction, priced at NOK 242 per share, is part of Medistim's long-term incentive plan, approved by the general meeting on May 8th, 2025. Following this acquisition, Karim now directly holds 2,211 Medistim shares.

The incentive plan also states that if Karim remains in his position after three years, he will be awarded an additional 1,474 Medistim shares free of charge. This aligns his interests with the company's long-term performance and shareholder value. Medistim ASA confirmed the sale. After this transaction, the company's own holding of shares stands at 62,032.